Cargando…
Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
BACKGROUND: Patients with stage I-III gastric cancer (GC) undergoing R0 radical resection display extremely different prognoses. How to discriminate high-risk patients with poor survival conveniently is a clinical conundrum to be solved urgently. METHODS: Patients with stage I-III GC from 2010 to 20...
Autores principales: | You, Weiqiang, Cai, Zerong, Sheng, Nengquan, Yan, Li, Wan, Huihui, Wang, Yongkun, Ouyang, Jian, Xie, Lu, Wu, Xiaojian, Wang, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987912/ https://www.ncbi.nlm.nih.gov/pubmed/35402221 http://dx.doi.org/10.3389/fonc.2022.848783 |
Ejemplares similares
-
Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
por: You, Weiqiang, et al.
Publicado: (2020) -
Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study
por: Ren, Jiazi, et al.
Publicado: (2021) -
The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
por: You, Weiqiang, et al.
Publicado: (2019) -
Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
por: You, Weiqiang, et al.
Publicado: (2022) -
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018)